RUA Life Sciences is developing products targeting billion-dollar global healthcare markets, which, if successfully commercialised it will generate significant value for the company. The current raise will support the business as it seeks to deliver the growth opportunities within its Contract Manufacturing business unit and commercialise and partner its lead vascular graft products and its heart valve leaflet composite material. We believe the company offers an attractive combination of establi ....
01 Dec 2023
RUA Life Sciences - Billion-dollar markets
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
RUA Life Sciences - Billion-dollar markets
RUA Life Sciences Plc (RUA:LON) | 10.8 0.1 4.9% | Mkt Cap: 6.67m
- Published:
01 Dec 2023 -
Author:
Chris Donnellan -
Pages:
22
RUA Life Sciences is developing products targeting billion-dollar global healthcare markets, which, if successfully commercialised it will generate significant value for the company. The current raise will support the business as it seeks to deliver the growth opportunities within its Contract Manufacturing business unit and commercialise and partner its lead vascular graft products and its heart valve leaflet composite material. We believe the company offers an attractive combination of establi ....